To identify the potential of NMUR1 as a biomarker in CRC, our study first conducted a comprehensive analysis of the function of NMUR1 in pan-cancer, including NMUR1 expression profiles, epigenetic alteration, the impact of survival, correlation with immune infiltration and associated pathways in 33 types of cancer. The gene discussed is NMUR1; the disease is colorectal carcinoma.